The Anti-NMDA Receptor Encephalitis Foundation Newsletter
Posted on January 20, 2019
Lecture: What is being done to improve encephalitis for the future? Speakers: Dr Sarosh Irani, John Radcliffe Hospital, Oxford Dr Rachel Kneen, Alder Hey Chi…
|
antipsychotic agents make affected patients much worse, even to the point of developing something akin to neuroleptic malignant syndrome.
|
World Encephalitis Day is the global awareness day for people who have been directly or indirectly affected by encephalitis. Founded by The Encephalitis Society in the UK in 2014, it is held on February 22 each year and has reached over 80 million people in the past five years.
|
Brain Dev. 2019 Jan 10. pii: S0387-7604(18)30140-2. doi: 10.1016/j.braindev.2018.12.009.[Epub ahead of print]…
|
1. A score that predicts one year functional status in anti-NMDA receptor encephalitis patients. 2. [What’s Trending]: Part 2: Drug pricing and the Institute for Clinical and Economic Review framework. In the first segment, Dr. David Lapides talks with Dr. Ramani Balu about his paper on a score that predicts one year functional status in anti-NMDA receptor encephalitis patients. In the second part of the podcast, you’ll hear the the second part of Dr. Gordon Smith’s interview with Dr. Steve Pearson on the Institute for Clinical and Economic Review and drug pricing. DISCLOSURES: Dr. David Lapides has served as a consultant for Boa Read More
|
|
Psychiatry Clin Neurosci. 2019 Jan 17. doi: 10.1111/pcn.12821.[Epub ahead of print]…
|
Rituximab is a widely used B-cell-depleting monoclonal antibody. It is unlicensed for use in neurological disorders and there are no treatment guidelines. However, as a rapidly acting, targeted therapy with growing evidence of efficacy and tolerability in several neuroinflammatory disorders, it is…
|
Objective: To determine the causative pathogen and investigate the effective treatment of a new type of encephalomyelitis with an unknown pathogen in Japan and report the preliminary ultrastructural and genomic characterization of the causative agent.
|
A 50-year-old woman with a recent diagnosis of poorly differentiated nonteratomatous cervicouterine cancer presented to our hospital for breath-holding episodes resulting in perioral cyanosis. Her medical history was significant for chickenpox at age 8 and shingles at age 15.
|
The water in the Duke Children’s Hospital Pediatric Bone Marrow unit is ridiculously delicious. It has to be.The floor is full of children who have had their immune systems suppressed so their……
|
|
|